Sulforaphane protects human chondrocytes against cell death induced by various stimuli

Journal of Cellular Physiology

Volumn 226, Issue 7, 2011, Pages 1771-1779

  Facchini, Annalisa ^a   Stanic, Ivana ^a   Cetrullo, Silvia ^a   Borzì, Rosa Maria ^b   Filardo, Giuseppe ^b   Flamigni, Flavio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; SULFORAPHANE;

APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CASPASES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL1; CHONDROCYTES; CYCLOHEXIMIDE; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SPERMINE; THIOCYANATES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955026286     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22506     Document Type: Article

References (33)

1. Aigner T, Kim HA. 2002. Apoptosis and cellular vitality: Issues in osteoarthritic cartilage degeneration. Arthritis Rheum 46:1986-1996.
2. Angeloni C, Leoncini E, Malaguti M, Angelini S, Hrelia P, Hrelia S. 2009. Modulation of phase II enzymes by sulforaphane: Implications for its cardioprotective potential. J Agric Food Chem 57:5615-5622.
3. Borzi RM, Olivotto E, Pagani S, Vitellozzi R, Neri S, Battistelli M, Falcieri E, Facchini A, Flamigni F, Penzo M, Platano D, Santi S, Facchini A, Marcu KB. 2010. Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors. Arthritis Rheum 62:2370-2381.
4. Clarke JD, Dashwood RH, Ho E. 2008. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269:291-304.
5. Del Carlo M, Jr., Loeser RF. 2008. Cell death in osteoarthritis. Curr Rheumatol Rep 10:37-42.
6. Finger F, Schorle C, Zien A, Gebhard P, Goldring MB, Aigner T. 2003. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum 48:3395-3403.
7. Flamigni F, Stanic I, Facchini A, Cetrullo S, Tantini B, Borzi RM, Guarnieri C, Caldarera CM. 2007. Polyamine biosynthesis as a target to inhibit apoptosis of non-tumoral cells. Amino Acids 33:197-202.
8. Gao X, Talalay P. 2004. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci USA 101:10446-10451.
9. Gao X, Dinkova-Kostova AT, Talalay P. 2001. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: The indirect antioxidant effects of sulforaphane. Proc Natl Acad Sci USA 98:15221-15226.
10. Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A. 2003. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J 166:140-158.
11. Healy ZR, Lee NH, Gao X, Goldring MB, Talalay P, Kensler TW, Konstantopoulos K. 2005. Divergent responses of chondrocytes and endothelial cells to shear stress: Cross-talk among COX-2, the phase 2 response, and apoptosis. Proc Natl Acad Sci USA 102:14010-14015.
12. Henrotin YE, Bruckner P, Pujol JP. 2003. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11:747-755.
13. Henrotin Y, Kurz B, Aigner T. 2005. Oxygen and reactive oxygen species in cartilage degradation: Friends or foes? Osteoarthritis Cartilage 13:643-654.
14. Higgins LG, Kelleher MO, Eggleston IM, Itoh K, Yamamoto M, Hayes JD. 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol Appl Pharmacol 237:267-280.
15. Hu R, Hebbar V, Kim BR, Chen C, Winnik B, Buckley B, Soteropoulos P, Tolias P, Hart RP, Kong AN. 2004. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 310:263-271.
16. Juge N, Mithen RF, Traka M. 2007. Molecular basis for chemoprevention by sulforaphane: A comprehensive review. Cell Mol Life Sci 64:1105-1127.
17. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, Aggarwal A, Aggarwal BB. 2007. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7:344-351.
18. Kim HA, Yeo Y, Kim WU, Kim S. 2009. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes. Rheumatology (Oxford) 48:932-938.
19. Kuhn K, D'Lima DD, Hashimoto S, Lotz M. 2004. Cell death in cartilage. Osteoarthritis Cartilage 12:1-16.
20. Malaguti M, Angeloni C, Garatachea N, Baldini M, Leoncini E, Collado PS, Teti G, Falconi M, Gonzalez-Gallego J, Hrelia S. 2009. Sulforaphane treatment protects skeletal muscle against damage induced by exhaustive exercise in rats. J Appl Physiol 107:1028-1036.
21. Olivotto E, Vitellozzi R, Fernandez P, Falcieri E, Battistelli M, Burattini S, Facchini A, Flamigni F, Santi S, Facchini A, Borzi RM. 2007. Chondrocyte hypertrophy and apoptosis induced by GROalpha require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B. J Cell Physiol 210:417-427.
22. Olivotto E, Borzi RM, Vitellozzi R, Pagani S, Facchini A, Battistelli M, Penzo M, Li X, Flamigni F, Li J, Falcieri E, Facchini A, Marcu KB. 2008. Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. Arthritis Rheum 58:227-239.
23. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, So HS, Park R, Kwon KB, Park BH. 2009. Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway. Toxicol Appl Pharmacol 235:57-67.
24. Stanic I, Facchini A, Borzi RM, Vitellozzi R, Stefanelli C, Goldring MB, Guarnieri C, Facchini A, Flamigni F. 2006. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha. J Cell Physiol 206:138-146.
25. Stanic I, Cetrullo S, Facchini A, Stefanelli C, Borzi RM, Tantini B, Guarnieri C, Caldarera CM, Flamigni F. 2008. Effect of the polyamine analogue N(1), N(11)-diethylnorspermine on cell survival and susceptibility to apoptosis of human chondrocytes. J Cell Physiol 216:153-161.
26. Stanic I, Facchini A, Borzi RM, Stefanelli C, Flamigni F. 2009. The polyamine analogue N1, N11-diethylnorspermine can induce chondrocyte apoptosis independently of its ability to alter metabolism and levels of natural polyamines. J Cell Physiol 219:109-116.
27. Tarozzi A, Morroni F, Merlicco A, Hrelia S, Angeloni C, Cantelli-Forti G, Hrelia P. 2009. Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem 111:1161-1171.
28. Vauzour D, Buonfiglio M, Corona G, Chirafisi J, Vafeiadou K, Angeloni C, Hrelia S, Hrelia P, Spencer JP. 2010. Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol Nutr Food Res 54:532-542.
29. Verkerk R, Schreiner M, Krumbein A, Ciska E, Holst B, Rowland I, De Schrijver R, Hansen M, Gerhauser C, Mithen R, Dekker M. 2009. Glucosinolates in Brassica vegetables: The influence of the food supply chain on intake, bioavailability and human health. Mol Nutr Food Res 53:S219.
30. Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, Park BH. 2008. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol 75:2214-2223.
31. Zhu H, Jia Z, Misra BR, Zhang L, Cao Z, Yamamoto M, Trush MA, Misra HP, Li Y. 2008a. Nuclear factor E2-related factor 2-dependent myocardiac cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 8:71-85.
32. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y. 2008b. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: Cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 8:115-125.
33. Zhu H, Jia Z, Zhang L, Yamamoto M, Misra HP, Trush MA, Li Y. 2008c. Antioxidants and phase 2 enzymes in macrophages: Regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Exp Biol Med (Maywood) 233:463-474.